Not all individuals with CLL require therapy. In spite of all recent advances, the iwCLL continue to suggests watchful observation for sufferers with asymptomatic disorder.86 This suggestion is based on at the very least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). MERDEKA77 https://ambroseq643rzh1.jasperwiki.com/user